SCHEMBL24676481

SCHEMBL24676481

CS(=O)(=O)N1CCC(Nc2cc(-c3sc(N[C@H]4CCC[C@@H]4O)nc3C(F)(F)F)c(F)cn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCND1 P24385 13/20 0.40
CDK6 Q00534 13/20 0.40
CDK2 P24941 13/20 0.40
CDK4 P11802 7/20 0.40
CCND3 P30281 7/20 0.40
CCNA2 P20248 3/20 0.40
TDO2 P48775 1/20 0.39
CCNE1 P24864 10/20 0.39
GPR119 Q8TDV5 1/20 0.38
CDK1 P06493 3/20 0.37
CCNB1 P14635 3/20 0.37
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
CDK7 P50613 2/20 0.37
CCNH P51946 2/20 0.37
DYRK2 Q92630 1/20 0.36
CCNT1 O60563 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676830 0.89 CCND1 (0.39) CCND1CDK6CDK2CDK4CCND3
SCHEMBL29754964 0.89 CDK2 (0.49) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676002 0.89 CDK2 (0.49) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676950 0.87 TDO2 (0.42) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676777 0.85 CDK2 (0.51) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676773 0.85 CDK2 (0.51) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676671 0.85 CDK2 (0.51) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676472 0.82 TDO2 (0.42) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676824 0.81 TDO2 (0.43) CCND1CDK6CDK2CDK4CCND3
SCHEMBL24676701 0.79 GPR119 (0.42) CCND1CDK6CDK2CDK4CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed